Prognostic factors in breast cancer.
作者信息
Miller W R
出版信息
Br J Cancer. 1992 Nov;66(5):775-6. doi: 10.1038/bjc.1992.358.
Abstract
摘要
相似文献
1
Prognostic factors in breast cancer.乳腺癌的预后因素。
Br J Cancer. 1992 Nov;66(5):775-6. doi: 10.1038/bjc.1992.358.
2
Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer.DNA倍体和S期分数在乳腺癌中的预后意义缺乏
Br J Cancer. 1992 Nov;66(5):925-9. doi: 10.1038/bjc.1992.387.
3
4
[DNA ploidy pattern, S-phase fraction as a prognostic factor of breast cancers].[DNA倍体模式、S期分数作为乳腺癌的预后因素]
Nihon Rinsho. 2000 Apr;58 Suppl:401-6.
5
S-phase fraction is a prognostic factor in stage I breast carcinoma.
J Clin Oncol. 1993 Sep;11(9):1717-22. doi: 10.1200/JCO.1993.11.9.1717.
6
[New factors of possible prognostic value in breast cancer].
Gan To Kagaku Ryoho. 1992 Jan;19(1):8-13.
7
Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?原发性肿瘤中的DNA倍体和S期分数能否预测转移性乳腺癌对化疗的反应？
Br J Cancer. 1995 May;71(5):1029-32. doi: 10.1038/bjc.1995.198.
8
Biological parameters in breast cancer.
Ann N Y Acad Sci. 1996 Apr 30;784:521-4. doi: 10.1111/j.1749-6632.1996.tb16274.x.
9
[Proliferative activity and ploidy of DNA as possible prognostic factors in breast cancer].
Klin Lab Diagn. 1996 May-Jun(3):37-8.
10
[DNA flow cytometric analysis in primary breast cancer. S-phase and ploidy status as prognostic factors and their correlation to tumor-associated proteolytic factors].[原发性乳腺癌的DNA流式细胞术分析。S期和倍体状态作为预后因素及其与肿瘤相关蛋白水解因子的相关性]
Gynakol Geburtshilfliche Rundsch. 1993;33 Suppl 1:303-4. doi: 10.1159/000272275.
引用本文的文献
1
Effect of a cytotoxic analog of LH-RH (T-98) on the growth of estrogen-dependent MXT mouse mammary cancers: correlations between growth characteristics and EGF receptor content of tumors.促黄体生成素释放激素（LH-RH）的细胞毒性类似物（T-98）对雌激素依赖性MXT小鼠乳腺癌生长的影响：肿瘤生长特征与表皮生长因子（EGF）受体含量之间的相关性
Breast Cancer Res Treat. 1996;40(2):129-39. doi: 10.1007/BF01806208.
2
Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma.单克隆抗体Ki-S1作为增殖活性的一种新标志物，在淋巴结阴性乳腺癌中缺乏预后意义。
Breast Cancer Res Treat. 1996;37(2):123-33. doi: 10.1007/BF01806494.
本文引用的文献
1
Different opinions on classification of DNA histograms produced from paraffin-embedded tissue.对石蜡包埋组织DNA直方图分类的不同观点。
Cytometry. 1989 Nov;10(6):711-7. doi: 10.1002/cyto.990100607.
2
Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors.倍性、增殖活性与预后。实体瘤的DNA流式细胞术。
Cancer. 1990 Mar 1;65(5):1194-205. doi: 10.1002/1097-0142(19900301)65:5<1194::aid-cncr2820650528>3.0.co;2-m.
3
Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry.淋巴结阴性乳腺癌：由肿瘤大小和流式细胞术定义的预后亚组。
J Clin Oncol. 1990 Dec;8(12):2040-6. doi: 10.1200/JCO.1990.8.12.2040.
4
Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast.通过流式细胞术对乳腺浸润性腺癌进行倍性分析和S期分数测定。
Am J Surg Pathol. 1991 Apr;15(4):358-67. doi: 10.1097/00000478-199104000-00004.
5
Breast cancer prognostic factors: evaluation guidelines.乳腺癌预后因素：评估指南
J Natl Cancer Inst. 1991 Feb 6;83(3):154-5. doi: 10.1093/jnci/83.3.154.
6
Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.S期分数在低风险、淋巴结阴性乳腺癌患者中的预后意义。
J Clin Oncol. 1992 Mar;10(3):428-32. doi: 10.1200/JCO.1992.10.3.428.
7
Is DNA flow cytometry a useful investigation in breast cancer?
Eur J Cancer. 1992;28(2-3):504-7. doi: 10.1016/s0959-8049(05)80088-7.
Zotero 插件